Charatzoglou Georgios M MD is categorized under Internal Medicine Doctors in Wynnewood, PA and active since 2006.
Charatzoglou Georgios M MD was established in 2006, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Georgios Charatzoglou at the company’s single location by writing to 1001 City Avenue Unit Wb113, Wynnewood, Pennsylvania PA 19096 or by phoning (610) 896-0280. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Charatzoglou Georgios M MD |
Contact Person: | Georgios Charatzoglou |
Address: | 1001 City Avenue Unit Wb113, Wynnewood, Pennsylvania 19096 |
Phone Number: | (610) 896-0280 |
Annual Revenue (USD): | $500.000 to $999.999 |
Founded: | 2006 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Internal Medicine Doctors |
SIC Code: | 8011 |
NAICS Code: | 6211110 |
Share This Business: |
Charatzoglou Georgios M MD was started in 2006 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Georgios Charatzoglou for inquiries that concern Charatzoglou Georgios M MD by calling the company number (610) 896-0280, as your correspondence is most welcome. Additionally, the physical location of the single location of Charatzoglou Georgios M MD can be found at the coordinates 39.984234,-75.261283 as well as the street address 1001 City Avenue Unit Wb113 in Wynnewood, Pennsylvania 19096.
For its online presence, you may visit Charatzoglou Georgios M MD’s website at and engage with its social media outlets through on Twitter and on Facebook.